InvestorsObserver
×
News Home

RenovoRx Inc (RNXT) is down -11.25% in a Week, Should You Accumulate?

Thursday, May 04, 2023 01:40 PM | InvestorsObserver Analysts

Mentioned in this article

RenovoRx Inc (RNXT) is down -11.25% in a Week, Should You Accumulate?

The 65 rating InvestorsObserver gives to RenovoRx Inc (RNXT) stock puts it near the top of the Biotechnology industry. In addition to scoring higher than 75 percent of stocks in the Biotechnology industry, RNXT’s 65 overall rating means the stock scores better than 65 percent of all stocks.

Overall Score - 65
RNXT has an Overall Score of 65. Find out what this means to you and get the rest of the rankings on RNXT!

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.
These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With RenovoRx Inc Stock Today?

RenovoRx Inc (RNXT) stock is trading at $2.76 as of 12:47 PM on Thursday, May 4, a decline of -$0.10, or -3.49% from the previous closing price of $2.86. The stock has traded between $2.71 and $3.15 so far today. Volume today is below average. So far 4,500 shares have traded compared to average volume of 53,029 shares. Click Here to get the full Stock Report for RenovoRx Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App